CAS NO: | 1073549-11-7 |
包装 | 价格(元) |
1mg | 电议 |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
100mg | 电议 |
生物活性 | TD-0212 TFA is an orally active dual pharmacologyangiotensin II type 1 receptor (AT1)antagonist andneprilysin(NEP)inhibitor, with apKiof 8.9 for AT1and apIC50of 9.2 for NEP[1]. | ||||||||||||||||
IC50& Target | pKi: 8.9 (AT1) | ||||||||||||||||
体外研究 (In Vitro) | TD-0212 provides the enhanced activity of dual AT1/NEP inhibition with a potentially lower risk of angioedema relative to dual ACE/NEP inhibition[1]. | ||||||||||||||||
体内研究 (In Vivo) | TD-0212 produces blood pressure reductions similar to omapatrilat and combinations of AT1 receptor antagonists and NEP inhibitors in models of renin-dependent and -independent hypertension[1]. | ||||||||||||||||
分子量 | 641.67 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C30H35F4N3O6S | ||||||||||||||||
CAS 号 | 1073549-11-7 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | -20°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) | ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 125 mg/mL(194.80 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|